Ministries of Health and Economics Analyze Plan to Lower Drug Prices: Sheinbaum
6 Articles
6 Articles
Reading time approx.: 1 minutes, 23 secondsIn light of the observation that the prices of medicines continue to rise despite the strength of the weight and the reduction in the costs of imported inputs, President Claudia Sheinbaum said that her administration already reviews the issue in coordination with the secretariats of Economy and Health, with the aim of promoting a decrease in consumer prices.
Mexico. The secretariats of Economy and Health analyze mechanisms to reduce drug prices, said President Claudia Sheinbaum Pardo. “It is not a question of putting a cap on prices, much less, but rather talking to pharmaceuticals and marketers because there are medicines with an excess cost, especially patent ones.” It may be of interest to you: It demands that pharmaceutical companies “take it seriously” and comply with the delivery of medicines …
Considering that in some cases the price is exaggerated, the Government of the Republic analyzes how to reduce the cost of medicines in private pharmacies, says President Claudia Sheinbaum. “And it is an important issue because... Complete note »
President Claudia Sheinbaum announced that the government is working on a strategy to lower the price of medicines because “there are some that are excessive.” “We’re looking at it with economy and health to see what mechanisms are being promoted to lower prices. It’s not about putting caps, let alone talking to pharmacists and marketers.” Currently there is the purchase of medicines mainly in pharmacies or private medical institutions, but the …
CDMX. President Claudia Sheinbaum Pardo acknowledged that there are medicines whose cost is excessive, particularly patent ones, and said that her government analyses mechanisms to promote a price reduction in coordination with the secretariats of Economy and Health.The approach came after being questioned at the morning conference for the increase in prices reported on medicines marketed by pharmaceutical companies, especially in pharmacies and…
President Claudia Sheinbaum said that, in coordination with the Ministries of Health and Economics, mechanisms are being studied to reduce the price of patent medicines, with the aim of making them more accessible to the population.She clarified that it is not a question of imposing direct ceilings on prices, but of dialogue with pharmaceutical and marketing companies to ensure that excessive costs, mainly of patent medicines, are reviewed.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium


